基于生粉的皮克林乳液:一种用于抗癌药物输送的创新平台
Patrizia Formoso1, Domenico Mammolenti2, Adele Chimento1
1Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, CS, Italy.
Molecules (Basel, Switzerland)
|November 27, 2025
概括
生粉稳定了新的皮克林乳液,可以有效地输送多克索鲁比辛. 这些可生物降解的配方显示出良好的药物捕获,持续释放和抗瘤功效,表明有针对性的癌症治疗的潜力.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 制药科学 制药科学
背景情况:
- 可生物降解的皮克林乳液提供了多功能治疗应用.
- 对于先进的药物输送系统,需要新的稳定剂.
研究的目的:
- 为配方和表征生粉稳定皮克林乳液,用于 doxorubicin 输送.
- 评估开发系统的物理化学性质,药物负载,释放动力学和体外疗效.
主要方法:
- 使用DLS,POM,Cryo-SEM,TEM和风湿学进行物理化学表征.
- 在不同的pH值下进行体外药物释放研究.
- 在纤维细胞和乳腺癌细胞的体外细胞毒性测定.
主要成果:
- 生粉稳定皮克林乳液 (GA4_Pe) 呈现出极好的稳定性 (>1个月) 和类似凝的特性.
- 载有多克索鲁比的乳液 (GA4_Pe@DOX) 显示有效的药物内化和稳定性 (>28天).
- 观察到持续的,依赖pH值的多克索鲁比释放,在酸性pH值下释放的更高.
- GA4_Pe@DOX在MCF7细胞上显示出与自由多克索鲁素相似的细胞毒性作用,对纤维细胞无毒性.
结论:
- 生粉是一种可行的稳定剂,用于制造稳定,可生物降解的皮克林乳液,用于药物输送.
- 开发的皮克林乳液平台促进了高效的多克索鲁比辛捕获和持续释放.
- 这种以生为基础的系统显示出作为一种选择性治疗平台的承诺,用于局部输送抗瘤药物.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
174
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
174
Drug Delivery: Overview
693
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
693
Bioavailability Enhancement: Drug Permeability Enhancement
163
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
163


